Hypermethylation Of ADHFE1 Promotes The Proliferation Of Colorectal Cancer Cell Via Modulating Cell Cycle Progression
Open Access
- 1 October 2019
- journal article
- research article
- Published by Taylor & Francis Ltd in OncoTargets and Therapy
- Vol. ume 12, 8105-8115
- https://doi.org/10.2147/OTT.S223423
Abstract
Background: Colorectal cancer (CRC) is one of the most common malignancies worldwide. Studies have demonstrated that epigenetic modifications play essential roles in the development of CRC. ADHFE1 is a differentially expressed gene that has been reported to be hypermethylated in CRC. However, the role and mechanism of ADHFE1 in the proliferation of CRC remain unclear. Materials and methods: ADHFE1 expression was analyzed in CRC tissues by IHC and qRT-PCR, and the relationship between ADHFE1 expression and the clinicopathological parameters was analyzed. Cell proliferation were assessed by the in vitro and in vivo experimental models. GSEA assay was performed to explore the mechanism of ADHFE1 in the proliferation of CRC. Flow cytometry and Western blot were used to detect the activation of the cell cycle signaling. Bisulfite genomic sequence (BSP) assay was used to test the methylation degree of ADHFE1 gene promoter in CRC tissues. Results: Here, we verified that ADHFE1 was down-regulated and hypermethylated in CRC tissues. The down-regulation of ADHFE1 was correlated with poor differentiation and advanced TNM stage of CRC patients. And ADHFE1 expression restored when the CRC cell line SW620 was treated with the demethylating agent 5-Aza-CdR. Overexpression of ADHFE1 inhibited the proliferation of CRC, while ADHFE1 knockdown promoted the proliferation of CRC cells in vitro and in vivo. Moreover, ADHFE1 overexpression could induce a significant G1-S cell cycle arrest in CRC cells and vice versa. Conclusion: Hypermethylation of ADHFE1 might promote cell proliferation by modulating cell cycle progression in CRC, potentially providing a new therapeutic target for CRC patients.Keywords
This publication has 33 references indexed in Scilit:
- microRNA-224 Promotes Cell Proliferation and Tumor Growth in Human Colorectal Cancer by Repressing PHLPP1 and PHLPP2Clinical Cancer Research, 2013
- Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChipsEpigenetics, 2013
- Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiologyOncogene, 2013
- Alcohol dehydrogenase, iron containing, 1promoter hypermethylation associated with colorectal cancer differentiationBMC Cancer, 2013
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomasInternational Journal of Cancer, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Genetics, Cytogenetics, and Epigenetics of Colorectal CancerJournal of Biomedicine and Biotechnology, 2011
- Epigenomic Analysis of Aberrantly Methylated Genes in Colorectal Cancer Identifies Genes Commonly Affected by Epigenetic AlterationsAnnals of Surgical Oncology, 2011
- Enzymes involved in the metabolism of γ-hydroxybutyrate in SH-SY5Y cells: Identification of an iron-dependent alcohol dehydrogenase ADHFe1Chemico-Biological Interactions, 2009